GLG Life Tech Corp., a global leader in the agricultural and commercial development of high quality natural sweeteners, announces that it has submitted a Generally Recognized as Safe (GRAS) notification with the United States Food and Drug Administration (FDA) for its high-purity Rebaudioside C stevia extract product.
This notification represents many months of work to develop the product and all required documentation under the FDA-administered GRAS process to demonstrate that GLG's Rebaudioside C extract meets the FDA's criteria for safety. This included in-depth consultation with GRAS Associates LLC, who convened an independent panel of scientists to spearhead this safety assessment.
GLG believes that it is the first company to submit GRAS notification to the FDA for Rebaudioside C. Consistent with its role as a leader in the sweetener industry, GLG continues to be at the forefront of stevia-related GRAS certifications. It has the largest number of stevia products certified under the GRAS process including high-purity Rebaudioside A and other Rebaudioside A products, high-purity stevioside, high-purity Rebaudioside M and now high-purity Rebaudioside C. Additionally, GRAS work is currently underway for high-purity Rebaudioside D.
Beyond stevia, the company has also submitted a GRAS application for luo han guo extracts of various purities, currently pending FDA review. These many submissions and certifications demonstrate GLG's commitment to ensuring that its full complement of naturally sourced sweetener products is compliant with the FDA GRAS program. GLG's stevia and luo han guo sweetener products will always be naturally sourced.